EC Number   |
Title |
Organism |
|---|
    2.4.1.267 | Novel genetic variants of ALG6 and GALNTL4 of the glycosylation pathway predict cutaneous melanoma-specific survival |
Homo sapiens |
| 2.4.1.267 | Structure and mechanism of the ER-based glucosyltransferase ALG6 |
Saccharomyces cerevisiae |
| 2.4.1.267 | A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency |
Homo sapiens |
| 2.4.1.267 | Analysis of multiple mutations in the hALG6 gene in a patient with congenital disorder of glycosylation Ic |
Homo sapiens |
| 2.4.1.267 | Engineering Yarrowia lipolytica to produce glycoproteins homogeneously modified with the universal Man3GlcNAc2 N-glycan core |
Yarrowia lipolytica |
| 2.4.1.267 | Identification of a frequent variant in ALG6, the cause of congenital disorder of glycosylation-Ic |
Homo sapiens |
| 2.4.1.267 | Isolation of the ALG6 locus of Saccharomyces cerevisiae required for glucosylation in the N-linked glycosylation pathway |
Saccharomyces cerevisiae |
| 2.4.1.267 | Reduced expression of the oligosaccharyltransferase exacerbates protein hypoglycosylation in cells lacking the fully assembled oligosaccharide donor |
Cricetulus griseus |
| 2.4.1.267 | Reduced expression of the oligosaccharyltransferase exacerbates protein hypoglycosylation in cells lacking the fully assembled oligosaccharide donor |
Homo sapiens |
| 2.4.1.267 | Skeletal dysplasia with brachytelephalangy in a patient with a congenital disorder of glycosylation due to ALG6 gene mutations |
Homo sapiens |
